Max Kilberg is a former founder turned investor at Village Global who leads pre-seed and seed rounds globally with a focus on helping companies go from zero to one, particularly in frontier AI areas like agentic and embodied AI through deals like Maisa, MicroAGI, and Aris Machina. He combines scientific rigor from his background co-authoring peer-reviewed immunology publications with hands-on founder support, positioning himself as a day-zero conviction backer who stays deeply involved through subsequent milestones and raises.